In the Boardroom
Refine Search
Pharmaceutical
Israel-based Medison, a creator of a first-of-its-kind unified global commercialization platform that accelerates the launch of breakthrough therapies, has announced two key additions to its global leadership team: Shay Tamari as chief business officer (CBO) and Tali Mirsky as chief legal and compliance officer (CLCO). 19 June 2025
Pharmaceutical
Australian biotech PolyActiva has brought in seasoned pharma executive Jerry St Peter as chief executive, in a leadership shake-up timed with a fresh $25 million financing round and a push to commercialize its lead eye implant therapy in the USA. 19 June 2025
Biotechnology
Cambridge, UK-based Maxion Therapeutics today announced the appointment of Dr Stefan Härtle as chief development officer, effective immediately. 17 June 2025
Biotechnology
Boston, USA-based biotech Solu Therapeutics today announced the appointment of Enda Moran as chief operating officer (COO). 16 June 2025
Pharmaceutical
Symbiosis Pharmaceutical Services (Symbiosis), a global contract manufacturing organization (CMO) specializing in sterile manufacture of injectable drug products, has appointed Angelika Rublack as senior business development manager to support its expanding global client base and drive growth across several territories. 13 June 2025
Biotechnology
US clinical-stage biotech Oncolytics Biotech today announced the appointment of Jared Kelly as chief executive (CEO) and a member of its board of directors. 11 June 2025
Pharmaceutical
UK-based microbiome company Microbiotica has appointed Robert Tansley its chief medical officer (CMO). 10 June 2025
Biotechnology
Swiss pharma company Idorsia today announced the appointment of Dr Srishti Gupta as chief executive (CEO), effective July 1, 2025. 10 June 2025
Biotechnology
US ophthalmic gene therapy company Beacon Therapeutics, which is focused on restoring the vision of patients with blinding retinal diseases, has appointed Daniel Chung as chief medical officer (CMO). 9 June 2025
Biotechnology
France-based SparingVision, a genomic medicine company focused on the treatment of retinal disease, has announced the appointment of Kalliopi ‘Kali’ Stasi, as chief medical officer, effective immediately. 9 June 2025
Pharmaceutical
UK pharma major GSK has appointed Sanjay Gurunathan as senior vice president and global head vaccines and infectious disease R&D. 9 June 2025
Pharmaceutical
US cardiorenal-focussed drugmaker Ardelyx announced that Mike Kelliher, formerly executive vice president, corporate development and strategy, has been promoted to chief business officer, and James Brady has joined the company as chief human resources officer. 6 June 2025
Pharmaceutical
Danish dermatology specialist LEO Pharma has appointed Helle Hedegaard Juhl as executive vice president for global people and corporate affairs (GPCA). 4 June 2025
Biotechnology
Netherlands-based biotech VectorY Therapeutics, which is developing treatments for neurodegenerative diseases, today announced the appointment of Jessica Atkinson as Chief Business Officer (CBO). 2 June 2025
Pharmaceutical
Swiss biotech iOnctura has appointed Steven Sciuto as chief financial officer and Michelle Tsai as chief operating officer, marking a leadership shift as the company moves deeper into Phase II trials for its lead cancer candidate, roginolisib (IOA-244). 2 June 2025
Pharmaceutical
US biotech Hillstar Bio has appointed Maude Tessier as chief operating officer and Shiva Krupa as vice president of program management, reinforcing its leadership bench ahead of a planned clinical entry for its lead autoimmune program in 2026. 29 May 2025
Biotechnology
Swedish biotech Hansa Biopharma is preparing to reduce its headcount by around one-fifth as part of a restructuring plan aimed at sharpening operational focus and reducing costs. 27 May 2025
Pharmaceutical
Danish privately-held drugmaker MC2 Therapeutics today announced the appointment of Trine Ahlgreen as chief executive (CEO). 27 May 2025
Biotechnology
UK biotech Nucleome Therapeutics has appointed Bhavna Hunjan as chief business officer, a move that strengthens its leadership as it advances its pipeline of antibody therapies for inflammatory diseases. 27 May 2025
Pharmaceutical
USA-based nonprofit CureDuchenne has announced the appointment of Brenda Wong as its new chief medical advisor (CMA), effective January 5, 2026. 22 May 2025
Biotechnology
Klaus Edvardsen has been named chief medical officer (CMO) of Epitopea, an Anglo-Canadian company developing off-the-shelf RNA-based immunotherapies. 7 February 2025
Pharmaceutical
US pharma giant Pfizer today announced that Jeffrey Legos will join the company as chief oncology officer. 6 February 2025
Biotechnology
Affinia Therapeutics, a US biotech with a pipeline of rationally designed adeno-associated virus (AAV) gene therapies for cardiovascular and neurological diseases, has announced the appointment of Hideo Makimura as its chief medical officer (CMO). 5 February 2025
Pharmaceutical
Not satisfied with simply changing personnel, Japanese drugmaker Astellas has announced a new management structure, effective April 1. 5 February 2025
Pharmaceutical
Uvax Bio, a privately held vaccine developer founded in 2018 as a spin-off from Scripps Research, has appointed chief business officer Kevin O’Neill as interim chief executive. 4 February 2025
Biotechnology
Faisal Sukhtian has been appointed as chairman of the board of directors at Outlook Therapeutics], effective immediately. 3 February 2025
Generics
Swiss generic and biosimilars drugmaker Sandoz today revealed that Francisco Ballester, president Region International and a member of the Sandoz executive committee, will retire and step down from the SEC on March 1, 2025. 3 February 2025
Pharmaceutical
Japanese drugmaker Daiichi Sankyo has appointed Hiroyuki Okuzawa to succeed Sunao Manabe, as chief executive (CEO), effective April 1, 2025. 1 February 2025
Pharmaceutical
In a long-term succession plan, the board of directors at Japan’s largest drugmaker Takeda has made the decision unanimously to appoint Julie Kim as the successor to Christophe Weber, Takeda’s president, chief executive (CEO) and representative director, when Mr Weber retires from the company in June 2026. 30 January 2025
Pharmaceutical
Swiss pharm giant Roche today announced that Wafaa Mamilli will join the company as chief digital technology officer (CDTO), reporting to group chief executive Thomas Schinecker. 29 January 2025
Pharmaceutical
Newly-launched obesity company Kailera Therapeutics has announced the appointment of Jamie Coleman as chief commercial officer (CCO). 28 January 2025
Biotechnology
Boston, USA-based biotech Averna Therapeutics (formerly known as Exsilio Therapeutics), revealed yesterday that it has appointed Thomas Barnes as its chief executive (CEO) and director. 28 January 2025
Biotechnology
Swarm Oncology, a biotech developing novel T cell therapies to achieve long-term remission in patients with advanced solid cancers, has emerged from stealth mode and announced the appointment of Martin Olin as chief executive. 27 January 2025
Pharmaceutical
The board of LINK Medical has announced the appointment of Anders Göransson as the new chief executive (CEO) of the Norwegian contract research organization (CRO). 27 January 2025
Pharmaceutical
Neurocrine Biosciences has announced the appointment of Andrew Ratz as senior VP of drug development, supporting the firm’s expanding R&D efforts. 24 January 2025
Biotechnology
Danish biotech Genmab (CPH: GMAB) today announced it has named Leslie Amendola senior vice president and general manager of its US business. 24 January 2025
Biotechnology
Kyverna Therapeutics (Nasdaq: KYTX), a California biotech developing CAR-T therapies for autoimmune diseases, has appointed Naji Gehchan as chief medical officer. 22 January 2025
Biotechnology
Arvinas has announced a change in its commercial leadership, with John Northcott stepping down from his role as chief commercial officer, due to personal reasons. 21 January 2025
Biotechnology
Dutch biotech Pharming Group today announced that its board of directors has nominated Fabrice Chouraqui to become the company’s new executive director and chief executive, succeeding Sijmen de Vries. 21 January 2025
Pharmaceutical
UK clinical-stage specialty pharma firm Actimed Therapeutics has appointed Dr Fabio Dorigotti as chief medical officer (CMO) following the retirement of previous CMO, Dr Frank Misselwitz. 16 January 2025
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze